Sunday, 25 August 2019

Market Survey News

  • Aurobindo Pharma revamps strategy to accelerate growth

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo has developed its market base in over 125 countries across the globe ...Read more

  • ResMed builds on partnerships for growth

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisitions and product expansion in the European region in 2011. ResMed took...Read more

  • Bioscience Industry clocks $139 bn, grows 8.37%

    Market Survey |  Analysis | By Nandita Singh | 0 Comment | 03 Jul, 2012

    The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 2009 slowdown, it was a single digit show in 2011 too. The industry reco...Read more

  • Sigma Pharma leverages on its pharmacy business

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained its No 3 rank slot in the BioSpectrum Asia list of Top 20 publicly lis...Read more

  • Shenzhen Neptunus invests in drug innovation

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical products in China. The company is known for manufacturing approximately 400 ...Read more

  • China holds largest pharma revenue share in APAC

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest share of the market. According to the BioSpectrum Top 20 survey, the y...Read more

  • China secures rank 1 in terms of total company revenues

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. Table legend:Country R...Read more

  • China, Australia dominate APAC pharma market

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 2011, riding on various factors, including an ever increasing population...Read more

  • China National Accord's R&D strategy begins to pay-off

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scientific development by implementing new medical reforms fostered by Chine...Read more

  • India's 127-year-old ayurvedic leader clocks $847 mn

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufacturing traditional ayurvedic products that passes rigorous trials and au...Read more

  • What were Asia's Top 20 bio companies in 2012?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording a double-digit growth of 11.07 percent over $139 billion of 2011. Aro...Read more

  • What were the top 20 global M&A transactions of 2012?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek out partners for mergers &am...Read more

  • Why did mergers & acquisitions plunge in APAC?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the number of deals struck ...Read more

  • Sanjiu Medical keeps focus on R&D

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medical instruments. The company also operates in pharmaceutical trading a...Read more

  • TCM leader Yunnan Baiyao rides on R&D strength

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on strengthening its R&D base. Recognized as a leading traditional Chine...Read more

  • Baraclude tops Korea pharma products list

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top three markets in Asia. China has the biggest market share, while Austral...Read more

  • Lipitor leads in Australia

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

  • Guangzhou records a whopping growth of over 50%

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognized name in China, Guangzhou Pharmaceutical Holdings is principally eng...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls